SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-20-054672
Filing Date
2020-11-19
Accepted
2020-11-19 17:02:27
Documents
12
Period of Report
2020-11-13
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K flxn-8k_20201113.htm   iXBRL 8-K 31655
  Complete submission text file 0001564590-20-054672.txt   160086

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA flxn-20201113.xsd EX-101.SCH 5804
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE flxn-20201113_lab.xml EX-101.LAB 19469
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE flxn-20201113_pre.xml EX-101.PRE 11651
5 EXTRACTED XBRL INSTANCE DOCUMENT flxn-8k_20201113_htm.xml XML 3555
Mailing Address 10 MALL ROAD SUITE 301 BURLINGTON MA 01803
Business Address 10 MALL ROAD SUITE 301 BURLINGTON MA 01803 (781) 305-7777
Flexion Therapeutics Inc (Filer) CIK: 0001419600 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36287 | Film No.: 201329484
SIC: 2834 Pharmaceutical Preparations